SHANGHAI BAO PHARMACEUTICALS CO., LTD. - B - H SHARES
(HKEX: 2659)
Shanghai Bao Pharmaceutical Co. Ltd. engages in the research and development of pharmaceutical products. It focuses on the following therapeutic areas: subcutaneous delivery, antibody-mediated auto-immune diseases, assisted reproduction, and synthetic biology upgrading platform. The company was founded by Yan Jun Liu and Zheng Wang on December 16, 2019 and is headquartered in Shanghai, China.
26.440 -
-1.040
(-3.78%)
Range
26.300 - 29.600
(12.55%)
Open
28.200
Previous Close
27.480
Bid Price
26.440
Bid Volume
('000)
20
Ask Price
26.460
Ask Volume
('000)
3.9
Volume
('000)
8,708.3
Value
242,214,234
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
